Our Board of Directors
Our board is comprised of years of leadership and professional experience; each is committed to our mission to raise awareness and funds in the fight against pediatric cancer.
NCI News Releases
14 April 2021
The latest cancer news from the U.S. government's principal agency for cancer research.-
Engineered immune cells deliver anticancer signal, prevent cancer from spreading
In an NCI study, treating mice with engineered immune cells shrank tumors and prevented the cancer from spreading to other parts of the body. The immunotherapy approach shows promise as a potential treatment for metastatic cancer.
-
NCI statement on ending structural racism in biomedical research
Statement from the National Cancer Institute in support of the NIH UNITE initiative to end structural racism in biomedical research. NCI Director Dr. Norman Sharpless describes NCI’s equity and inclusion efforts.
-
NCI study finds that people with SARS-CoV-2 antibodies may have a low risk of future infection
A prior infection with SARS-CoV-2, the virus that causes COVID-19, appears to protect, at least for a few months, against reinfection from the virus, according to an NCI study. The finding may have important public health implications.
NCI Fact Sheets
14 April 2021
The latest NCI fact sheets on a wide array of cancer topics including risk factors, prevention, support, treatment, and more.-
Tumor Markers
A fact sheet that defines tumor markers and describes how they can be used to aid diagnosis and treatment.
-
Targeted Cancer Therapies
A fact sheet that describes targeted cancer therapies, which are drugs that interfere with specific molecules involved in cancer cell growth and survival.
-
Genetic Testing for Inherited Cancer Susceptibility Syndromes
A fact sheet about genetic testing for inherited cancer risk, including who should consider testing, how to understand test results, and who has access to a person’s test results. Also contains information about at-home, or direct-to-consumer, genetic tests.
